185 related articles for article (PubMed ID: 17497355)
1. Controlled release of methotrexate from w/o microemulsion and its in vitro antitumor activity.
Karasulu HY; Karabulut B; Göker E; Güneri T; Gabor F
Drug Deliv; 2007 Apr; 14(4):225-33. PubMed ID: 17497355
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies.
Kantarci G; Ozgüney I; Karasulu HY; Arzik S; Güneri T
AAPS PharmSciTech; 2007 Nov; 8(4):E91. PubMed ID: 18181551
[TBL] [Abstract][Full Text] [Related]
3. Preparation of arsenic trioxide-loaded microemulsion and its enhanced cytotoxicity on MCF-7 breast carcinoma cell line.
Karasulu HY; Karabulut B; Kantarci G; Ozgüney I; Sezgin C; Sanli UA; Göker E
Drug Deliv; 2004; 11(6):345-50. PubMed ID: 15736829
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.
Ofner CM; Pica K; Bowman BJ; Chen CS
Int J Pharm; 2006 Feb; 308(1-2):90-9. PubMed ID: 16361072
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
Abdelbary G; Haider M
Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
[TBL] [Abstract][Full Text] [Related]
9. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of methotrexate-loaded microcapsules.
Genç L; Büyüktıryakı S
Pharm Dev Technol; 2014 Feb; 19(1):42-7. PubMed ID: 23368981
[TBL] [Abstract][Full Text] [Related]
11. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
[TBL] [Abstract][Full Text] [Related]
12. Preparation of curcumin microemulsions with food-grade soybean oil/lecithin and their cytotoxicity on the HepG2 cell line.
Lin CC; Lin HY; Chi MH; Shen CM; Chen HW; Yang WJ; Lee MH
Food Chem; 2014 Jul; 154():282-90. PubMed ID: 24518344
[TBL] [Abstract][Full Text] [Related]
13. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
14. Optimization of nanostructured lipid carriers loaded with methotrexate: A tool for inflammatory and cancer therapy.
Ferreira M; Chaves LL; Lima SA; Reis S
Int J Pharm; 2015 Aug; 492(1-2):65-72. PubMed ID: 26169145
[TBL] [Abstract][Full Text] [Related]
15. The effect of molecular weight, drug load, and charge of gelatin-MTX conjugates on growth inhibition of HL-60 leukemia cells.
Chen CS; Ofner CM
Pharm Res; 2009 Feb; 26(2):338-45. PubMed ID: 18975058
[TBL] [Abstract][Full Text] [Related]
16. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
17. Inorganic nanovehicle targets tumor in an orthotopic breast cancer model.
Choi G; Kwon OJ; Oh Y; Yun CO; Choy JH
Sci Rep; 2014 Mar; 4():4430. PubMed ID: 24651154
[TBL] [Abstract][Full Text] [Related]
18. β-Cyclodextrin-based biodegradable dendrimers for drug delivery.
Tang J; Wang X; Wang X; Sui M; Mao W; Shen Y
J Control Release; 2011 Nov; 152 Suppl 1():e89-90. PubMed ID: 22195948
[No Abstract] [Full Text] [Related]
19. Macromolecular bipill of gemcitabine and methotrexate facilitates tumor-specific dual drug therapy with higher benefit-to-risk ratio.
Das M; Jain R; Agrawal AK; Thanki K; Jain S
Bioconjug Chem; 2014 Mar; 25(3):501-9. PubMed ID: 24506698
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the percutaneous penetration of indomethacin from soybean oil microemulsion: effects of the HLB value of mixed surfactants.
Chen L; Tan F; Wang J; Liu F
Pharmazie; 2012 Jan; 67(1):31-6. PubMed ID: 22393828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
